← FDA DRUG APPROVALS

FDA ANDA · ANDA065435

PENICILLIN V POTASSIUM

Sponsor: AUROBINDO PHARMA

APPLICATION
ANDA065435
TYPE
ANDA
ORIGINAL APPROVAL
2008-04-29
LATEST ACTION
2014-08-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PENICILLIN V POTASSIUMPrescription
PENICILLIN V POTASSIUM EQ 250MG BASE · TABLET · ORAL
PENICILLIN V POTASSIUMPrescription
PENICILLIN V POTASSIUM EQ 500MG BASE · TABLET · ORAL

Approval history

2014-08-05Labeling · Supplement 5 · standardAP
2008-04-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →